Recognising nicotine: The neurobiological basis of nicotine discrimination

Handbook of Experimental Pharmacology

Volumn 192, Issue , 2009, Pages 295-333

  Stolerman, Ian P ^a   Smith, Janice W ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ARECOLINE; ATROPINE; CAFFEINE; CANNABINOID; CHLORISONDAMINE; CLOZAPINE; COCAINE; CYTISINE; DEXTROMETHORPHAN; DEXTRORPHAN; DIHYDRO BETA ERYTHROIDINE; HALOPERIDOL; HEXAMETHONIUM; LOBELINE; MECAMYLAMINE; METHYLLYCACONITINE; MIDAZOLAM; MORPHINE; NALOXONE; NALTREXONE; NICOTINE; OXOTREMORINE; PENTOLONIUM TARTRATE; PHENELZINE; PHYSOSTIGMINE; SCOPOLAMINE; UNINDEXED DRUG; VARENICLINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

BEHAVIOR; BRAIN REGION; CENTRAL NERVOUS SYSTEM; COGNITION; CONCENTRATION RESPONSE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; GROUPS BY AGE; HIPPOCAMPUS; HUMAN; NEUROANATOMY; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PERCEPTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SEX DIFFERENCE; SMOKING CESSATION; STIMULUS; TOBACCO DEPENDENCE; TRAINING; VENTRAL TEGMENTUM; ANIMAL; DISCRIMINATION LEARNING; DRUG INTERACTION; FEMALE; MALE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISCRIMINATION LEARNING; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; TOBACCO USE DISORDER;

EID: 63849331334     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-69248-5_11     Document Type: Review

References (174)

1. Ator NA, Griffiths RR (2003) Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 70(Suppl 1):S55-S72
2. 2A/2C receptor agonists. Psychopharmacology 179:393-401
3. Bencherif M, Fowler K, Lukas RJ, Lippiello PM (1995) Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther 275:987-994
4. Benwell MEM, Balfour DJK Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles. Psychopharmacology 63:1979
5. Bondarev ML, Bondareva TS, Young R, Glennon RA (2003) Behavioral and biochemical investigations of bupropion metabolites. European Journal of Pharmacology 474:85-93
6. Brauer LH, Behm FM, Westman EC, Patel P, Rose JE (1999) Naltrexone blockade of nicotine effects in cigarette smokers. Psychopharmacology 143:339-346
7. Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, Campbell JE, Decker MW, Donnelly-Roberts D, Elliott RL, Gopalakrishnan M, Holladay MW, Hui Y-H, Jackson WJ, Kim DJB, Marsh KC, O'Neill A, Prendergast MA, Ryther KB, Sullivan JP, Arneric SP (1997) Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav 57:231-241
8. Brioni JD, Kim DJB, O'Neill AB, Williams JEG, Decker MW (1994) Clozapine attenuates the discriminative stimulus properties of (-)-nicotine. Brain Res 643:1-9
9. Brioni JD, Kim DJB, Brodie MS, Decker MW, Arneric SP (1995) ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity. Psychopharmacology 119:368-378
10. Brioni JD, Kim DJB, O'Neill AB (1996) Nicotine cue: lack of effect of the α7nicotinic receptor antagonist methyllycaconitine. Eur J Pharmacol 301:1-5
11. Brioni JD, Kim DJB, O'Neill A, Brodie MS, Decker MW, Arneric SP (1997) ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxly)pyridine dihydrochloride]: discriminative stimulus properties and electrophysiological actions. Drug Dev Res 40:259-266
12. Buchkremer G, Bents H, Minneker E, Opitz K (1988) Long-term effects of a combination of transdermal nicotine administration with behavior therapy for smoking cessation. Nervenarzt 59:488-490 (in German)
13. Casas M, Ferre S, Cobos A, Grau JM, Jane F (1989) Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway. Neuropharmacology 28:407-409
14. Cohen C, Perrault G, Voltz C, Steinberg R, Soubrié P (2002) SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451-463
15. Chance WT, Murfin D, Krynock GM, Rosecrans JA (1977) A description of the nicotine stimulus and tests of its generalization to amphetamine. Psychopharmacology 55:19-26
16. Chance WT, Kallman MD, Rosecrans JA, Spencer RM (1978) A comparison of nicotine and structurally related compounds as discriminative stimuli. Br J Pharmacol 63:609-616
17. Chandler CJ, Stolerman IP (1997) Discriminative stimulus properties of the nicotinic agonist cytisine. Psychopharmacology 129:257-264
18. Clark MS, Rand MJ, Vanov S (1965) Comparison of pharmacological activity of nicotine and related alkaloids occurring in cigarette smoke. Arch Int de Pharmacodynamie et de Therapie 156:363-379
19. Clarke PBS, Pert CB, Pert A (1984) Autoradiographic distribution of nicotine receptors in rat brain. Brain Res 323:390-395
20. Cohen C, Bergis OE, Galli F, Lochead AW, Jegham S, Biton B, Leonardon J, Avenet P, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Voltz C, Gardes A, Caille D, Perrault G, George P, Soubrié P, Scatton B (2003) SSR591813, a novel selective and partial α4β2 nicotinic receptor agonist with potential as an aid to smoking cessation. J Pharmacol Exp Ther 306: 407-420
21. Colombo G, Agabio R, Balaklievskaia N, Lobina C, Reali R, Fadda F, Gessa GL (1996) T-maze and food reinforcement: an inexpensive drug discrimination procedure. J Neurosci Methods 67:83-87
22. Corrigall WA, Coen KM (1991) Selective dopamine antagonists reduce nicotine self- administration. Psychopharmacology 104:171-176
23. Corrigall WA, Coen KM (1994) Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus. Pharmacol Biochem Behav 48:817-820
24. Corrigall WA, Herling S, Coen KM (1988) Evidence for opioid mechanisms in the behavioral effects of nicotine. Psychopharmacology 96:29-35
25. CorrigallWA, Franklin KBJ, Coen KM, Clarke PBS (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107:285-289
26. Craft RM, Howard JL (1988) Cue properties of oral and transdermal nicotine in the rat. Psychopharmacology 96:281-284
27. Craft RM, Milholland RB (1998) Sex differences in cocaine- and nicotine-induced antinociception in the rat. Brain Res 809:137-140
28. Cronan T, Conrad J, Bryson R (1985) Effects of chronically administered nicotine and saline on motor activity in rats. Pharmacol Biochem Behav 22:897-899
29. Damaj MI, Glassco W, Marks MJ, Slobe B, James JR, May EL, Rosecrans JA, Collins AC, Martin BR (1997) Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h] isoquinoline, a bridged-nicotine analog. J Pharmacol Exp Ther 282:1425-1434
30. David V, Besson M, Changeux JP, Granon S, Cazala P (2006) Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacology 50:1030-1040
31. de la Garza R, Johanson C-E (1983) The discriminative stimulus properties of cocaine in the rhesus monkey. Pharmacol Biochem Behav 19:145-148
32. Decker MW, Anderson DJ, Brioni JD, Donnelly-Roberts DL, Kang CH, O'Neill AB, Piattoni-Kaplan M, Swanson S, Sullivan JP (1995) Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 280:79-89
33. Dekeyne A, Girardon S, Millan MJ (1999) Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, Ro 60-0175: a pharmacological analysis. Neuropharmacology 38:415-423
34. DeNoble VJ, Mele PC (2006) Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology 184:266-272
35. Desai RI, Barber DJ, Terry P (1999) Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine. Behav Pharmacol 10:647-656
36. Desai RI, Barber DJ, Terry P (2003) Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psychopharmacology 167:335-343
37. Di Chiara G (2000) Behavioural pharmacology and neurobiology of nicotine reward and dependence. In: Clementi F, Fornasari D, Gotti C (eds) Handbook of experimental pharmacology, vol. 144. Neuronal Nicotinic Receptors. Springer, Berlin, pp 603-750
38. Di Matteo V, Pierucci M, Esposito E (2004) Selective stimulation of serotonin2C receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J Neurochem 89:418-429
39. Etter J-F (2006) Cytisine for smoking cessation: a literature review and a meta-analysis. Arch Intern Med 166:1553-1559
40. Ferre S, Fuxe K, Von Euler G, Johansson B, Fredholm BB (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51:501-512
41. Fredholm BB, Battig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83-133
42. Garcha HS, Stolerman IP (1993) Discriminative stimulus effects of the nicotine antagonist mecamylamine in rats. J Psychopharmacol 7:43-51
43. Garcha HS, Stolerman IP (1989) Discrimination of a drug mixture in rats: role of training dose, and specificity. Behav Pharmacol 1:25-31
44. Gasior M, Shoaib M, Yasar S, Jaszyna M, Goldberg SR (1999) Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther 288:1053-1073
45. Gasior M, Jaszyna M, Peters J, Goldberg SR (2000) Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose. J Pharmacol Exp Ther 295:1101-1111
46. Gasior M, Jaszyna M, Munzar P, Witkin JM, Goldberg SR (2002) Caffeine potentiates the discriminative-stimulus effects of nicotine in rats. Psychopharmacology 162:385-395
47. Giorguieff-Chesselet MF, Kemel ML, Wandscheer D, Glowinski J (1979) Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effect of nicotine in a low concentration. Life Sci 25:1257-1261
48. Goldberg SR, Spealman RD (1983) Suppression of behavior by intravenous injections of nicotine or by electric shocks in squirrel monkeys: effects of chlordiazepoxide and mecamylamine. J Pharmacol Exp Ther 224:334-340
49. Goldberg SR, Risner ME, Stolerman IP, Reavill C, Garcha HS (1989) Nicotine and some related compounds: effects on schedule- controlled behaviour and discriminative properties in rats. Psychopharmacology 97:295-302
50. Gommans J, Stolerman IP, Shoaib M (2000) Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice. Neuropharmacology 39:2840-2847
51. Gordon TL, Meehan SM, Schechter D (1993) P and NP rats respond differently to the discriminative stimulus effects of nicotine. Pharmacol Biochem Behav 45:305-308
52. Grottick AJ, Corrigall WA, Higgins GA (2001) Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 157:292-298
53. Hahn B, Stolerman IP, Shoaib M (1999) Kappa-opioid receptor modulation of behavioural effects of nicotine. J Psychopharmacol 13(Suppl. A):A22
54. Hatchell PC, Collins AC (1977) Influences of genotype and sex on behavioral tolerance to nicotine in mice. Pharmacol Biochem Behav 6:25-30
55. Herrera-Marschitz M, Casas M, Ungerstedt U (1988) Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses. Psychopharmacology 94:38-45
56. Hiltunen AJ, Järbe TUC (1990) Acute tolerance to ethanol using drug discrimination and openfield procedures in rats. Psychopharmacology 102:207-212
57. Hirschhorn ID, Rosecrans JA (1973) Nicotine as a discriminative stimulus: the time course of the cue and the effect of receptor blockers. The Pharmacologist 15:236
58. Hirschhorn ID, Rosecrans JA (1974) Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine. Psychopharmacologia 40: 109-120
59. Holland PC (1991) Acquisition and transfer of occasion setting in operant feature positive and feature negative discriminations. Learn Motiv 22:366-387
60. Imperato A, Mulas A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine-release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338
61. James JR, Villanueva HF, Johnson JH, Arezo S, Rosecrans JA (1994) Evidence that nicotine can acutely desensitize central nicotine acetylcholinergic receptors. Psychopharmacology 114: 456-462
62. Jessup M (1996) Nicotine: a gateway drug? J Am Med Womens Assoc 51:21
63. Jung ME, Wallis CJ, Gatch MB, Lal H (2000) Sex differences in nicotine substitution to a pentylenetetrazol discriminative stimulus during ethanol withdrawal in rats. Psychopharmacology 149:235-240
64. Kanýt L, Stolerman IP, Chandler CJ, Saigusa T, Pogun S (1999) Influence of sex and female hormones on nicotine-induced changes in locomotor activity in rats. Pharmacol Biochem Behav 62:179-187
65. Kim DJB, Brioni JD (1995) Modulation of the discriminative stimulus properties of-nicotine by diazepam and ethanol. Drug Dev Res 34:47-54
66. Koek W, Slangen JL (1982) Effects of reinforcement differences between drug and saline sessions on discriminative stimulus properties of fentanyl. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier, Amsterdam, pp 343-354
67. Kumar R, Pratt JA, Stolerman IP (1983) Characteristics of conditioned taste aversion produced by nicotine in rats. British Journal of Pharmacology 79:245-253
68. Kumar R, Reavill C, Stolerman IP (1987) Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. Br J Pharmacol 90:239-246
69. Le Foll B, Goldberg SR (2004) Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. NeuroReport 15:2139-2143
70. Le Foll B, Goldberg SR (2005) Ethanol does not affect discriminative-stimulus effects of nicotine in rats. Eur J Pharmacol 519:96-102
71. Le Foll B, Goldberg SR (2006) Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology 184:367-381
72. Le Foll B, Goldberg SR, Sokoloff P (2005) The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neuropharmacology 49:525-541
73. Le Novère N, Corringer P-J, Changeux J-P (2002) The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 53:447-456
74. Li M, Garner HR, Wessinger WD, McMillan DE (1995) Effects of food deprivation and satiation on sensitivity to the discriminative-stimulus effects of pentobarbital in pigeons and morphine in rats. Behav Pharmacol 6:724-731
75. Lindström J, Peng X, Kuryatov A, Lee E, Anand R, Gerzanich V, Wang F, Wells G, Nelson M (1998) Molecular and antigenic structure of nicotinic acetylcholine receptors. Ann N Y Acad Sci 841:71-86
76. Luetje CW, Patrick J (1991) Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11:837-845
77. Mackintosh NJ (1974) The psychology of animal learning. Academic Press, London
78. Mansbach RS, Rovetti CC, Freedland CS (1998) The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus. Drug Alcohol Depend 52:125-134
79. Mansbach RS, Chambers LK, Rovetti CC (2000) Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine. Psychopharmacology 148:234-242
80. Mansvelder HD, McGehee DS (2000) Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27:349-357
81. Mariathasan EA, Stolerman IP (1993a) Overshadowing of nicotine discrimination in rats: a model for behavioural mechanisms of drug interactions? Behav Pharmacol 4:209-215
82. Mariathasan EA, Stolerman IP (1993b) Discrimination of agonist-antagonist mixtures: experiments with nicotine plus mecamylamine. Behav Pharmacol 4:555-561
83. Mariathasan EA, Garcha HS, Stolerman IP (1991) Discriminative stimulus effects of amphetamine and pentobarbitone separately and as mixtures in rats. Behav Pharmacol 2:405-415
84. Mariathasan EA, Stolerman IP, White J-AW (1997) Antagonism of AND and AND-OR drug mixture discrimination in rats. Drug Alcohol Depend 44:31-34
85. Marubio L, M, Gardier AM, Durier S, David D, Klink R, Arroyo-Jimenez MM, McIntosh JM, Rossi F, Champtiaux N, Zoli M, Changeux J-P (2003) Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci 17:1329-1337
86. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloez-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, David V, Faure P, Granon S, Changeux JP (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436:103-107
87. Massey BW, McMillan DE (1987) Effects of body weight on discriminative stimulus control by phencyclidine in the pigeon. J Exp Anal Behav 47:233-239
88. McMillan DE, Li M, Shide DJ (1999) Differences between alcohol-preferring and alcoholnonpreferring rats in ethanol generalization. Pharmacol Biochem Behav 64:415-419
89. McMillan DE, Wenger GR (1984) Bias of phencyclidine discrimination by the schedule of reinforcement. J Exp Anal Behav 42:51-66
90. McMillan DE, Li M, Hardwick WC (2001) Schedule control of quantal and graded dose-effect curves in a drug-drug-saline discrimination. Pharmacol Biochem Behav 68:395-402
91. Meltzer LT, Rosecrans JA (1981) Investigations on the CNS sites of action of the discriminative stimulus effects of arecoline and nicotine. Pharmacol Biochem Behav 15:21-26
92. Meltzer LT, Rosecrans JA, Aceto MD, Harris LS (1980) Discriminative stimulus properties of the optical isomers of nicotine. Psychopharmacology 68:283-286
93. Millan MJ, Girardon S, Bervoets K (1997) 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)(2C) agonist, RO 60-0175: blockade of its actions by the novel 5-HT(2C) receptor antagonist SE 206,553. Neuropharmacology 36: 743-745
94. Miyata H, Ando K, Yanagita T (2002) Brain regions mediating the discriminative stimulus effects of nicotine in rats. Ann N Y Acad Sci 965:354-363
95. Morrison CF, Stephenson JA (1969) Nicotine injections as the conditioned stimulus in discrimination learning. Psychopharmacologia 15:351-360
96. Overton DA (1977) Discriminable effects of antimuscarinics: dose response and substitution test studies. Pharmacol Biochem Behav 6:659-666
97. Overton DA (1982) Comparison of the degree of discriminability of various drugs using the t-maze drug discrimination paradigm. Psychopharmacology 76:385-395
98. Overton DA (1983) Test for a neurochemically specific mechanism mediating drug discriminations and for stimulus masking. Psychopharmacology 81:340-344
99. Palmatier MI, Peterson JL, Wilkinson JL, Bevins RA (2004) Nicotine serves as a feature-positive modulator of Pavlovian appetitive conditioning in rats. Behav Pharmacol 15:183-194
100. Palmatier MI, Wilkinson JL, Metschke DM, Bevins RA (2005) Stimulus properties of nicotine, amphetamine, and chlordiazepoxide as positive features in a Pavlovian appetitive discrimination task in rats. Neuropsychopharmacology 30:731-741
101. Paterson NE, Semenova S, Gasparini F, Markou A (2003) The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167:257-264
102. Perkins KA (1999) Nicotine discrimination in men and women. Pharmacol Biochem Behav 64:295-299
103. Perkins KA, DiMarco A, Grobe JE, Scierka A, Stiller RL (1994) Nicotine discrimination in male and female smokers. Psychopharmacology 116:407-413
104. Perkins KA, Fonte C, Meeker J, White W, Wilson A (2001) The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pretreatment. Behav Pharmacol 12: 35-44
105. Perkins KA, Fonte C, Stolinski A, Blakesley-Ball R, Wilson AS (2005) The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects. Exp Clin Psychopharmacol 13:275-81
106. Philibin SD, Vann RE, Varvel SA, Covington HE III, Rosecrans JA, James JR, Robinson SE (2005) Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacol Biochem Behav 80:87-92
107. Picciotto MR, ZoliM, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K, Changeux J-P (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-177
108. Pierucci M, Di Matteo V, Esposito E (2004) Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration. J Pharmacol Exp Ther 309:109-118
109. Pratt JA, Stolerman IP, Garcha HS, Giardini V, Feyerabend C (1983) Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology 81:54-60
110. Quarta D, Naylor CG, Barik J, Fernandes C, Wonnacott S, Stolerman IP (2008) Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release. Psychopharmacology, DOI 10:1007/s00213-008-1281-x
111. Quarta D, Naylor CG, Stolerman IP (2007) The serotonin2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination. Psychopharmacology 193:391-402
112. Reavill C, Stolerman IP (1987) Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats. J Psychopharmacol 1:264-273
113. Reavill C, Walther B, Stolerman IP, Testa B (1990) Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology 29:619-624
114. Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ (1993) Effects of systemic nicotine on serotonin release in rat brain. Brain Res 621:311-318
115. Robinson SE, James JR, Lapp LN, Vann RE, Gross DF, Philibin SD, Rosecrans JA (2006) Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance. Psychopharmacology 184:306-313
116. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD, Williams KE (2007) Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-997
117. Romano C, Goldstein A, Jewell NP (1981) Characterization of the receptor mediating the nicotine discriminative stimulus. Psychopharmacology 74:310-315
118. Rosecrans JA, Chance WT (1977) Cholinergic and noncholinergic aspects of the discriminative stimulus properties of nicotine. In: Lal H (ed) Discriminative stimulus properties of drugs. Plenum, New York, pp 155-185
119. Rosecrans JA, Chance WT (1978) The discriminative stimulus properties of n- and m-cholinergic receptor stimulants. In: Ho BT, Richards DWIII, Chute DL (eds) Drug discrimination and state dependent learning. Academic, New York, pp 119-130
120. Rosecrans JA, Schechter MD (1972) Brain area nicotine levels in male and female rats of two strains. Arch Int de Pharmacodynamie et de Therapie 196:46-54
121. Rosecrans JA, Kallman MJ, Glennon RA (1978) The nicotine cue: an overview. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier-North Holland, Amsterdam, pp 69-81
122. Salas R, Cook KD, Bassetto L, De Biasi M (2004) The α3 and β4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion. Neuropharmacology 47:401-407
123. Sanchez C, Arnt J, Didriksen M, Dragsted N, Lenz SM, Matz J (1998) In vivo muscarinic cholinergic mediated effects of Lu 25-109, aM1 agonist and M2/M3 antagonist in vitro. Psychopharmacology 137:233-240
124. Sannerud CA, Young AM (1987) Environmental modification of tolerance to morphine discriminative stimulus properties in rats. Psychopharmacology 93:59-68
125. Schechter MD (1973) Transfer of state-dependent control of discriminative behavior between subcutaneously and intraventricularly administered nicotine and saline. Psychopharmacologia 32:327-335
126. Schechter MD (1995) Scopolamine-physostigmine combination does not substitute for nicotine. Prog Neuropsychopharmacol Biol Psychiatr 19:499-508
127. SchechterMD, Meehan SM (1992) Further evidence for the mechanisms that may mediate nicotine discrimination. Pharmacol Biochem Behav 41:807-812
128. Schechter MD, Rosecrans JA (1971a) Behavioral evidence for two types of cholinergic receptor in the C.N.S. Eur J Pharmacol 15:375-378
129. Schechter MD, Rosecrans JA (1971b) C.N.S. effect of nicotine as the discriminative stimulus for the rat in a T-maze. Life Sci 10:821-832
130. Schechter MD, Rosecrans JA (1972) Nicotine as a discriminative cue in rats depleted of norepinephrine or 5-hydroxytryptamine. Psychopharmacologia 24:417-429
131. Schreiber R, Brocco M, Millan MJ (1994) Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99-102
132. Shoaib M, Stolerman IP (1996) Brain sites mediating the discriminative stimulus effects of nicotine in rats. Behav Brain Res 78:183-188
133. Shoaib M, Thorndike E, Schindler CW, Goldberg SR (1997) Discriminative stimulus effects of nicotine and chronic tolerance. Pharmacol Biochem Behav 56:167-173
134. Shoaib M, Swanner LS, Yasar S, Goldberg SR (1999) Chronic caffeine exposure potentiates nicotine self-administration in rats. Psychopharmacology 142:327-333
135. Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP (2002) The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42:530-539
136. Shoaib M, Sidhpura N, Shafait S (2003) Investigating the actions of bupropion on dependencerelated effects of nicotine in rats. Psychopharmacology 165:405-412
137. Smith JW, Mogg A, Tafi E, Peacey E, Pullar IA, Szekeres P, Tricklebank M (2007) Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology 190:157-170
138. Solinas M, Panlilio LV, Justinova Z, Yasar S, Goldberg SR (2006) Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats. Nat Protoc 1:1194-1206
139. Spealman RD (1983) Maintenance of behavior by postponement of scheduled injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 227:154-159
140. Stolerman IP (1987) Psychopharmacology of nicotine: stimulus effects and receptor mechanisms. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 19. Plenum, New York, pp 421-465
141. Stolerman IP (1989) Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology 97:131-138
142. Stolerman IP (1991) Measures of stimulus generalization in drug discrimination experiments. Behav Pharmacol 2:265-282
143. Stolerman IP (1999) Inter-species consistency in the behavioural pharmacology of nicotine dependence. Behav Pharmacol 10:559-580
144. Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats. Psychopharmacology 129:390-397
145. Stolerman IP, Garcha HS (1989) Temporal factors in drug discrimination: experiments with nicotine. J Psychopharmacol 3:88-97
146. Stolerman IP, Garcha HS (1994) Failure of 5-HT3 antagonists and other drugs to block the nicotine discriminative stimulus. In: Harris LS (ed) Problems of Drug Dependence 1993. NIDA Research Monograph 141. U.S. Department of Health and Human Services, Rockville, Maryland, p 67
147. Stolerman IP, Mariathasan EA (2003) Nicotine trace discrimination in rats with midazolam as a mediating stimulus. Behav Pharmacol 14:55-66
148. Stolerman IP, White J-AW (1996) Impact of training history on discrimination of a drug mixture by rats. Behav Pharmacol 7:483-494
149. Stolerman IP, Fink R, Jarvik ME (1973) Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 30:329-342
150. Stolerman IP, Pratt JA, Garcha HS, Giardini V, Kumar R (1983) Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology 22:1029-1037
151. Stolerman IP, Rauch RJ, Norris EA (1987) Discriminative stimulus effects of a nicotine-midazolam mixture in rats. Psychopharmacology 93:250-256
152. Stolerman IP, Naylor C, Elmer GI, Goldberg SR (1999) Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology 141:297-306
153. Stolerman IP, Childs E, Hahn B, Morley A (2002) Drug trace discrimination with nicotine and morphine in rats. Behav Pharmacol 13:49-58
154. Stolerman IP, Chamberlain S, Bizarro L, Fernandes C, Schalkwyk L (2004) The role of nicotinic receptor alpha7 subunits in nicotine discrimination. Neuropharmacology 46:363-371
155. Summers KL, Giacobini E (1995) Effects of local and repeated systemic administration of (-) nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem Res 20:753-759
156. Tanda G, Goldberg SR (2000) Alteration of the behavioral effects of nicotine by chronic caffeine exposure. Pharmacol Biochem Behav 66:47-64
157. Ukai M, Holtzman SG (1988) Restricted feeding does not modify discriminative stimulus effects of morphine in the rat. Pharmacol Biochem Behav 29:201-203
158. Van Haaren F, Anderson KG, Haworth SC, Kem WR (1999) GTS-21, a mixed nicotinic receptor agonist/antagonist, does not affect the nicotine cue. Pharmacol Biochem Behav 64:439-444
159. VarandaWA, Aracava Y, Sherby SM (1985) The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Mol Pharmacol 28:128-137
160. 3H-dopamine from rat brain slices. Neuropharmacology 13:693-700
161. White J-AW, Stolerman IP (1994) Antagonism of a nicotine plus midazolam discriminative cue in rats. Behav Pharmacol 5:351-355
162. White J-AW, Stolerman IP (1996) Reversal of overshadowing in a drug mixture discrimination in rats. Psychopharmacology 123:46-54
163. Wiley JL, James JR, Rosecrans JA (1996) Discriminative stimulus properties of nicotine: approaches to evaluating potential nicotinic receptor agonists and antagonists. Drug Dev Res 38:222-230
164. Wiley JL, LaVecchia KL, Martin BR, Damaj MI (2002) Nicotine-like discriminative stimulus effects of bupropion in rats. Exp Clin Psychopharmacol 10:129-135
165. Williams M, Robinson JL (1984) Binding of the nicotinic cholinergic antagonist, dihydro-betaerythroidine, to rat brain tissue. J Neurosci 4:2906-2911
166. Witkin JM, Dykstra LA, Carter RB (1982) Acute tolerance to the discriminative stimulus properties of morphine. Pharmacol Biochem Behav 17:223-228
167. Wooters TE, Bardo MT (2007) The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Behav Pharmacol 18:601-608
168. Wright JM Jr, Vann RE, Gamage TF, Damaj MI, Wiley JL (2006) Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats. Pharmacol Biochem Behav 85:507-513
169. Xu W, Gelber S, Orr-Urtreger A, Armstrong D, Lewis RA, Ou C, Patrick J, Role L, De Biasi M, Beaudet AL (1999) Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 96:5746-5751
170. Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113-118
171. Young R, Bondareva T,Wesolowska A, Young S, Glennon RA (2006) Effect of the 5-HT6 serotonin antagonist MS-245 on the actions of (-)nicotine. Pharmacol Biochem Behav 85:170-177
172. Zakharova ES, Danysz W, Bespalov AY (2005) Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats. Psychopharmacology 179:128-135
173. Zaniewska M, McCreary AC, Przegalinski E, Filip M (2006) Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 540:96-106
174. Zaniewska M, McCreary AC, Przegalinski E, Filip M (2007) Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 571:156-165